Deals
40 of 40 deals across all markets
Market | Customer | Quote Status | Deal Status | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BMH Cardiac Genomics Pilot | Germany | Berlin Metro Hospital Group | €960 | 6% | €883 | 76.8% | — | — | — | — | Quote/Auto-Approved | In Review |
| BMH Hereditary Cancer Extension | Germany | Berlin Metro Hospital Group | €940 | 19% | €724 | 65.5% | — | — | — | — | Quote/Needs Approval — Level 1 | In Review |
| EHS Community Screening Wave 3 | UK | Southeast England EHS Trust Group | €1,010 | 7% | €939 | 74.4% | — | — | — | — | Quote/Approved | Proposed to Customer |
| EHS Paediatric Rare Disease Bid | UK | Southeast England EHS Trust Group | €1,000 | 24% | €700 | 57.1% | — | — | — | — | Quote/Needs Approval — Level 2 | In Review |
| Paris Metro Neuro Panel Proposal | France | Paris Metropolitan Hospital Group | €900 | 8% | €810 | 71.6% | — | — | — | — | Quote/Approved | Proposed to Customer |
| Paris Metro Oncology Tender | France | Paris Metropolitan Hospital Group | €880 | 21% | €660 | 59.8% | — | — | — | — | Quote/Needs Approval — Level 1 | In Review |
| Madrid Primary Care Rollout Bid | Spain | Madrid Regional Hospital Group | €800 | 5% | €760 | 75.7% | — | — | — | — | Quote/Approved | Proposed to Customer |
| Madrid Transplant Monitoring Pilot | Spain | Madrid Regional Hospital Group | €780 | 26% | €530 | 43.4% | — | — | — | — | Quote/Needs Approval — Level 2 | In Review |
| NIRA Infectious Disease Panel Bid | Italy | Northern Italy Regional Health Authority | €790 | 11% | €687 | 74.5% | — | — | — | — | Quote/Approved | Proposed to Customer |
| BMH Oncology Panel Rollout | Germany | Berlin Metro Hospital Group | €950 | 5% | €884 | 75.7% | 104.9% | 17 Apr 2026 | 8 May 2026 | 7 May 2028 | Quote/Auto-Approved | Won — Active |
| BMH Expansion — Bavaria Labs | Germany | Berlin Metro Hospital Group | €940 | 18% | €714 | 30.0% | 88.1% | 7 Jan 2026 | 6 Feb 2026 | 6 Feb 2028 | Quote/Approved | Won — Active |
| BMH Liquid Biopsy Programme | Germany | Berlin Metro Hospital Group | €970 | 9% | €844 | 72.7% | 71.0% | 4 Sept 2026 | 25 Sept 2026 | 24 Sept 2028 | Quote/Auto-Approved | Won — Active |
| EHS Southeast Regional Screening | UK | Southeast England EHS Trust Group | €1,010 | 8% | €889 | 71.3% | 111.9% | 16 Feb 2026 | 23 Mar 2026 | 22 Mar 2028 | Quote/Auto-Approved | Won — Active |
| EHS Rapid Turnaround Pilot | UK | Southeast England EHS Trust Group | €1,020 | 30% | €673 | 37.6% | 40.8% | 31 Jul 2026 | 9 Sept 2026 | 8 Sept 2028 | Quote/Approved | Won — Active |
| EHS Trust Oncology Framework | UK | Southeast England EHS Trust Group | €1,000 | 6% | €920 | 74.5% | 96.0% | 21 Jul 2025 | 18 Aug 2025 | 18 Aug 2027 | Quote/Auto-Approved | Won — Active |
| Paris Metro Companion Dx | France | Paris Metropolitan Hospital Group | €900 | 6% | €846 | 61.0% | 66.5% | 6 Jun 2026 | 4 Jul 2026 | 3 Jul 2028 | Quote/Auto-Approved | Won — Active |
| Paris Metro Pharmacogenomics | France | Paris Metropolitan Hospital Group | €880 | 20% | €686 | 71.6% | 83.0% | 26 Jun 2026 | 31 Jul 2026 | 30 Jul 2028 | Quote/Approved | Won — Active |
| Paris Metro Maternal Health Panel | France | Paris Metropolitan Hospital Group | €910 | 12% | €764 | 73.2% | 118.0% | 19 Sept 2025 | 31 Oct 2025 | 31 Oct 2027 | Quote/Auto-Approved | Won — Active |
| Madrid Regional Genomics Access | Spain | Madrid Regional Hospital Group | €760 | 3% | €722 | 72.3% | 94.0% | 18 Mar 2026 | 29 Apr 2026 | 28 Apr 2028 | Quote/Auto-Approved | Won — Active |
| Madrid Volume Commit 2026 | Spain | Madrid Regional Hospital Group | €820 | 22% | €590 | 71.2% | 55.1% | 17 May 2026 | 11 Jun 2026 | 10 Jun 2028 | Quote/Approved | Won — Active |
| Madrid Hospital Network Renewal | Spain | Madrid Regional Hospital Group | €790 | 7% | €735 | 66.0% | 101.0% | 1 Jun 2025 | 6 Jul 2025 | 6 Jul 2027 | Quote/Auto-Approved | Won — Active |
| NIRA Rare Disease Program | Italy | Northern Italy Regional Health Authority | €790 | 12% | €664 | 73.6% | 108.7% | 6 Jul 2026 | 20 Jul 2026 | 19 Jul 2028 | Quote/Auto-Approved | Won — Active |
| NIRA Prenatal Panel Renewal | Italy | Northern Italy Regional Health Authority | €750 | 4% | €720 | 72.2% | 78.4% | 16 Jun 2026 | 4 Jul 2026 | 3 Jul 2028 | Quote/Auto-Approved | Won — Active |
| BMH Solid Tumour Panel 2024 | Germany | Berlin Metro Hospital Group | €920 | 10% | €810 | 72.8% | 92.1% | 4 Oct 2024 | 3 Nov 2024 | 3 Nov 2025 | Quote/Auto-Approved | Expired |
| BMH Pilot — Rhine Clinics | Germany | Berlin Metro Hospital Group | €900 | 23% | €657 | 42.2% | 46.9% | 1 Feb 2025 | 22 Feb 2025 | 19 Nov 2025 | Quote/Approved | Expired |
| EHS Winter Capacity Programme | UK | Southeast England EHS Trust Group | €1,000 | 9% | €910 | 73.1% | 124.0% | 3 Dec 2024 | 31 Dec 2024 | 27 Oct 2025 | Quote/Auto-Approved | Expired |
| Paris Metro Legacy Oncology Term | France | Paris Metropolitan Hospital Group | €870 | 14% | €731 | 71.3% | 87.1% | 5 Aug 2024 | 9 Sept 2024 | 9 Sept 2025 | Quote/Auto-Approved | Expired |
| Madrid Regional Pilot 2024 | Spain | Madrid Regional Hospital Group | €770 | 6% | €708 | 74.6% | 109.0% | 13 Dec 2024 | 24 Jan 2025 | 24 Jan 2026 | Quote/Auto-Approved | Expired |
| NIRA Cardio Panel Term 1 | Italy | Northern Italy Regional Health Authority | €780 | 8% | €686 | 72.3% | 68.2% | 3 Nov 2024 | 24 Nov 2024 | 24 Nov 2025 | Quote/Auto-Approved | Expired |
| NIRA Lapsed Screening Contract | Italy | Northern Italy Regional Health Authority | €760 | 27% | €509 | 35.2% | 38.0% | 13 Mar 2025 | 10 Apr 2025 | 6 Dec 2025 | Quote/Approved | Expired |
| EHS Genomic Medicine Service Wave 1 | UK | Southeast England EHS Trust Group | €1,000 | 5% | €930 | 74.2% | Ramping up | 16 Oct 2026 | 15 Dec 2026 | 15 Dec 2027 | Quote/Auto-Approved | Won — Not Started |
| BMH Deep Discount Request Q3 | Germany | Berlin Metro Hospital Group | €900 | 32% | €558 | 53.4% | — | — | — | — | Quote/Rejected | In Review |
| Madrid Regional Tender 2026 | Spain | Madrid Regional Hospital Group | €800 | 9% | €712 | 70.5% | — | — | — | — | Quote/Approved | Lost |
| Paris Metro Cardio Panel Bid | France | Paris Metropolitan Hospital Group | €890 | 12% | €783 | 68.7% | — | — | — | — | Quote/Approved | Lost |
| PHTC Precision Oncology Panel | Ireland | Private High-Tech Clinic | €890 | 4% | €837 | 72.5% | — | — | — | — | Quote/Auto-Approved | In Review |
| DCH Infectious Disease Screening Bid | Ireland | Dublin Central Hospital | €900 | 20% | €684 | 61.3% | — | — | — | — | Quote/Approved | Proposed to Customer |
| DCH Regional Genomics Rollout | Ireland | Dublin Central Hospital | €910 | 8% | €819 | 72.5% | 98.3% | 27 May 2026 | 24 Jun 2026 | 23 Jun 2028 | Quote/Auto-Approved | Won — Active |
| GBH Cardiac Panel Go-Live | Ireland | Galway Bay Hospital | €870 | 26% | €592 | 45.9% | Ramping up | 26 Sept 2026 | 18 Oct 2026 | 17 Oct 2028 | Quote/Approved | Won — Active |
| GBH Screening Programme 2024 | Ireland | Galway Bay Hospital | €850 | 9% | €757 | 73.6% | 104.1% | 13 Nov 2024 | 18 Dec 2024 | 18 Dec 2025 | Quote/Auto-Approved | Expired |
| PHTC Executive Health Term 1 | Ireland | Private High-Tech Clinic | €880 | 24% | €634 | 46.3% | 60.8% | 3 Mar 2025 | 24 Mar 2025 | 18 Jan 2026 | Quote/Approved | Expired |